JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

Search

Hologic Inc

Cerrado

SectorSalud

74.02 0.16

Resumen

Variación precio

24h

Actual

Mínimo

73.84

Máximo

74.1

Métricas clave

By Trading Economics

Ingresos

212M

195M

Ventas

19M

1B

P/B

Media del Sector

28.98

37.461

BPA

1.08

Margen de beneficio

19.037

Empleados

7,063

EBITDA

341M

334M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 meses

+5.51% upside

Dividendos

By Dow Jones

Próximas Ganancias

3 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

1.3B

16B

Apertura anterior

73.86

Cierre anterior

74.02

Noticias sobre sentimiento de mercado

By Acuity

25%

75%

51 / 371 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

Hologic Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

21 oct 2025, 13:20 UTC

Adquisiciones, fusiones, absorciones

Blackstone, TPG to Buy Hologic for Up to $18.3 Billion

27 may 2025, 18:46 UTC

Principales Movimientos del Mercado
Adquisiciones, fusiones, absorciones

Hologic Shares Up Following Report of Buyout Offer From TPG, Blackstone

21 oct 2025, 16:36 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Hologic Seen as Prime Take-Private Candidate -- Market Talk

21 oct 2025, 13:05 UTC

Adquisiciones, fusiones, absorciones

Blackstone, TPG to Buy Hologic for Up to $18.3B

21 oct 2025, 12:50 UTC

Adquisiciones, fusiones, absorciones

Hologic Plans to File Form 10-K for Fiscal 2025 With the SEC in Late Nov >HOLX

21 oct 2025, 12:49 UTC

Adquisiciones, fusiones, absorciones

Hologic Does Not Intend to Provide Fincl Guidance for FY26 in Upcoming 4Q Results Release

21 oct 2025, 12:48 UTC

Adquisiciones, fusiones, absorciones

Hologic Merger Agreement Includes a 45-Day 'Go-Shop' Period >HOLX

21 oct 2025, 12:48 UTC

Adquisiciones, fusiones, absorciones

Hologic Will Continue to Operate Under the Hologic Name and Brand >HOLX

21 oct 2025, 12:48 UTC

Adquisiciones, fusiones, absorciones

Hologic Will Maintain Its Headquarters in Marlborough, Massachusetts >HOLX

21 oct 2025, 12:47 UTC

Adquisiciones, fusiones, absorciones

Blackstone's Private Equity Strategy for Individual Investors Is Also Expected to Invest as Part of Transaction

21 oct 2025, 12:46 UTC

Adquisiciones, fusiones, absorciones

Blackstone and TPG Secured Committed Financing From Citi, Bank of Amer, Barclays, Royal Bank of Canada and SMBC

21 oct 2025, 12:46 UTC

Adquisiciones, fusiones, absorciones

Blackstone and TPG Have Secured Committed Financing for the Transaction >HOLX

21 oct 2025, 12:45 UTC

Adquisiciones, fusiones, absorciones

Hologic: Transaction Includes Significant Minority Investments From Subsidiary of Abu Dhabi Investment Authority and an Affil of GIC >HOLX

21 oct 2025, 12:45 UTC

Adquisiciones, fusiones, absorciones

Hologic: Purchase Price Represents Premium of About 46% to Closing Price on May 23 >HOLX

21 oct 2025, 12:45 UTC

Adquisiciones, fusiones, absorciones

Hologic: Non-tradable CVR Would Be Issued to Holders at Closing and Paid Following Achievement of Certain Global Rev Goals for Breast Health Business in FY26, FY27

21 oct 2025, 12:44 UTC

Adquisiciones, fusiones, absorciones

Blackstone and TPG Will Acquire Hologic Shrs for $76/Shr in Cash Plus Non-Tradable CVR to Get Up to $3/Shr for Total of Up to $79/Shr in Cash >HOLX

21 oct 2025, 12:42 UTC

Adquisiciones, fusiones, absorciones

Hologic: Transaction Will Help Strengthen Leadership in Women's Health and Accelerate Growth >HOLX

21 oct 2025, 12:42 UTC

Adquisiciones, fusiones, absorciones

Hologic to Be Acquired by Funds Managed by Blackstone Deal and TPG in Deal With Enterprise Value of Up to $18.3 B >BX HOLX

27 may 2025, 20:07 UTC

Adquisiciones, fusiones, absorciones

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. -- Barrons.com

27 may 2025, 19:06 UTC

Adquisiciones, fusiones, absorciones

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. -- Barrons.com

27 may 2025, 18:26 UTC

Adquisiciones, fusiones, absorciones

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 19%. -- Barrons.com

Comparación entre iguales

Cambio de precio

Hologic Inc Esperado

Precio Objetivo

By TipRanks

5.51% repunte

Estimación a 12 meses

Media 78 USD  5.51%

Máximo 94 USD

Mínimo 69 USD

De acuerdo con 13 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Hologic Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

13 ratings

3

Comprar

10

Mantener

0

Vender

Puntuación técnica

By Trading Central

52.69 / 58.605Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Weak Bearish Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

51 / 371 Clasificación en Salud

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Hologic Inc

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
help-icon Live chat